Page 26 - Ipos

Wakefit IPO opens for bidding: What investors should know

Wakefit Innovations has opened its much-anticipated IPO today. From price band and grey market premium to financials and expansion plans, here’s a simple, complete breakdown of what this public issue

Stock Market Highlights: Sensex tumbles 609 pts; Nifty ends below 26k; Realty cracks 3%; VIX up 8%

Sensex Today | Stock Market Highlights, December 8, 2025: In the broader markets, Nifty Midcap 100 index closed 1.83 per cent lower, while Nifty SmallCap 100 index settled 2.6 per cent lower

Investing in Nephrocare Health IPO? Check 5 key risks before you decide

Nephrocare Health IPO will be offered at a price band of ₹438 to ₹460 per share and a lot size of 32 shares

Park Medi World IPO opens Dec 10: GMP at 20%; 5 key risks you should know

The unlisted shares of Park Medi World were trading at ₹193 in the grey market, commanding a premium of ₹33 or 20 per cent from the upper end price of ₹162

Subscribed to Aequs IPO? Here's how to check allotment status, latest GMP

Once the allotment is finalised, investors who applied for the public offering can check their status on the official websites of BSE, NSE, or Kfin Technologies, the registrar for the issue

Wakefit Innovations IPO opens today: Check GMP, price band, dates, review

Ahead of its IPO, Wakefit Innovations raised ₹580 crore from 33 institutional investors via an anchor book on December 5

Meesho IPO subscribed 79x; check allotment status, GMP, listing date

Meesho IPO allotment: Applicants can verify their status through the NSE and BSE websites or by visiting the IPO registrar, Kfin Technologies

ICICI Prudential AMC to launch IPO on Dec 12 as Prudential sells 10% stake

Prudential will sell up to 49 million shares in the IPO, compared with an earlier plan of 17.7 million shares, ICICI Prudential said in a filing late on Friday

Last day to bid for Vidya Wires IPO: Check subscription status, GMP

Investors placed bids for 969 million shares in the Vidya Wires IPO, compared with the 43.33 million shares available, translating to a subscription level of 22.35 times

IPO Calendar: D-Street braces for 9 new issues; Meesho, Aequs listings

IPO Calendar: Nephrocare, Park Medi World, Wakefit Innovations, and Corona Remedies, are set to open for subscription, aiming to raise a combined ₹3,735 crore

Last day! Aequs IPO closes today; subscription rises 28x, GMP at 37%

Aequs IPO subscription status: Among the investor categories, retail investors led the demand, with the portion reserved for them subscribed by 56.62 times

Final hours! Heavy NII, retail bidding boosts Meesho IPO; GMP holds steady

Meesho IPO Day 3: Check latest subscription status, grey market premium (GMP), allotment date, listing date, and other key details here

Corona Remedies IPO opens Dec 8: Bid or skip? Here's what experts suggest

Corona Remedies IPO Date: The unlisted shares of Corona Remedies were trading at ₹1,427, commanding a grey market premium of ₹365 or 34.4 per cent on Friday

Park Medi World IPO opens Dec 10; sets price band at ₹154-162: Key details

Park Medi World is eyeing ₹770 crore through the fresh issue for 47.5 million equity shares, and shareholders will be selling 9.3 million equity shares through an OFS for ₹150 crore

Stock Market close: Sensex, Nifty snap 4-day losing streak; IT shares outperform; VIX down 4%

Sensex today | Stock Market close, Thursday, Dec 4: The Nifty MidCap index rose 0.30 per cent, while the Nifty SmallCap gained 0.1 per cent

Corona Remedies IPO opens Dec 8: GMP at 31%; 5 key risks you should know

Corona Remedies IPO will be offered at a price band of ₹1,008 to ₹1,062 per share, with a lot size of 14 shares

Meesho IPO booked 3x on strong demand; should you bid too? Analysts weigh

Analysts highlight Meesho's zero-commission, asset-light business model, coupled with its multi-sided marketplace and logistics network

Nephrocare Health sets IPO price band at ₹438-460: Check key details here

Nephrocare Health IPO will open for public subscription on Wednesday, December 10 and close on Friday, December 12

Wakefit IPO: D2C growth story, key risks ahead, what investors should know

According to the RHP, Wakefit's performance is heavily dependent on its "Wakefit" brand, under which it sells mattresses, furniture and home furnishings

Retail investors drive demand for Aequs IPO on Day 1, NIIs follow; QIBs lag

Retail investors have oversubscribed their reserved portion by 6.42 times, while non-institutional investors (NIIs) have closely followed, with their segment oversubscribed by 1.45 times